RA

Rosalind Advisors Portfolio holdings

AUM $207M
This Quarter Return
+27.19%
1 Year Return
+62.29%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$186M
AUM Growth
+$186M
Cap. Flow
-$34.3M
Cap. Flow %
-18.47%
Top 10 Hldgs %
69.28%
Holding
47
New
9
Increased
5
Reduced
10
Closed
10

Top Buys

1
CMRX
Chimerix, Inc.
CMRX
$10.6M
2
URGN icon
UroGen Pharma
URGN
$9.27M
3
SVRA icon
Savara
SVRA
$8.15M
4
FENC icon
Fennec Pharmaceuticals
FENC
$7.96M
5
VSTM icon
Verastem
VSTM
$4.65M

Top Sells

1
CRMD icon
CorMedix
CRMD
$11.9M
2
CLRB icon
Cellectar Biosciences
CLRB
$7.86M
3
VRNA
Verona Pharma
VRNA
$5.81M
4
OTLK icon
Outlook Therapeutics
OTLK
$2.4M
5
CYBN
Cybin
CYBN
$2.33M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TLPH icon
26
Talphera
TLPH
$11.2M
$322K 0.16%
613,939
-145,027
-19% -$76K
OWLT icon
27
Owlet
OWLT
$129M
$220K 0.11%
49,441
-220,559
-82% -$981K
RLMD icon
28
Relmada Therapeutics
RLMD
$48.8M
$52K 0.03%
+100,000
New +$52K
XNTK icon
29
SPDR NYSE Technology ETF
XNTK
$1.24B
– –
0
– –
XBI icon
30
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
VOR icon
31
Vor Biopharma
VOR
$253M
– –
-76,685
Closed -$53.7K
VERU icon
32
Veru
VERU
$48.5M
– –
-2,694,503
Closed -$2.07M
QQQ icon
33
Invesco QQQ Trust
QQQ
$364B
– –
0
– –
NAMS icon
34
NewAmsterdam Pharma
NAMS
$2.8B
– –
-10,123
Closed -$168K
LXRX icon
35
Lexicon Pharmaceuticals
LXRX
$392M
– –
0
– –
FBIO icon
36
Fortress Biotech
FBIO
$87.8M
– –
-502,828
Closed -$727K
EWTX icon
37
Edgewise Therapeutics
EWTX
$1.54B
– –
0
– –
DERM icon
38
Journey Medical
DERM
$169M
– –
-105,917
Closed -$598K
CRMD icon
39
CorMedix
CRMD
$1.02B
– –
-1,475,000
Closed -$11.9M
CLSD icon
40
Clearside Biomedical
CLSD
$26.7M
– –
-127,220
Closed -$162K
CLRB icon
41
Cellectar Biosciences
CLRB
$15.3M
– –
-3,671,550
Closed -$7.86M
CADL icon
42
Candel Therapeutics
CADL
$281M
– –
0
– –
BMEA icon
43
Biomea Fusion
BMEA
$114M
– –
0
– –
ABVX
44
Abivax
ABVX
$6.32B
– –
-139,983
Closed -$1.61M
OTLK icon
45
Outlook Therapeutics
OTLK
$39.5M
– –
-450,000
Closed -$2.4M
OEF icon
46
iShares S&P 100 ETF
OEF
$22.1B
– –
0
– –
NMRA icon
47
Neumora Therapeutics
NMRA
$283M
– –
0
– –
1
2